167 related articles for article (PubMed ID: 14529661)
1. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography.
Ueland FR; DePriest PD; Pavlik EJ; Kryscio RJ; van Nagell JR
Gynecol Oncol; 2003 Oct; 91(1):46-50. PubMed ID: 14529661
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW
AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975
[TBL] [Abstract][Full Text] [Related]
3. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
4. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.
Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB
Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883
[TBL] [Abstract][Full Text] [Related]
5. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
[TBL] [Abstract][Full Text] [Related]
6. Validity of colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Eur J Gynaecol Oncol; 1996; 17(1):29-35. PubMed ID: 8750512
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative assessment of benign and malignant ovarian tumours using colour Doppler ultrasonography.
Dasgupta S; Malty SP; Sharma PP; Mukhopadhyay A; Ghosh TK
J Indian Med Assoc; 2010 Aug; 108(8):495-7. PubMed ID: 21404744
[TBL] [Abstract][Full Text] [Related]
8. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
Salem S; White LM; Lai J
AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
[TBL] [Abstract][Full Text] [Related]
10. B-mode, utero-ovarian and intratumoural transvaginal colour Doppler ultrasonography for differential diagnosis of ovarian tumours.
Mercé LT; Caballero RA; Barco MJ; Bau S; López G
Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):97-107. PubMed ID: 9481556
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value estimation of the Doppler indicies: PI, RI and PSV, TAMXV and MEDV in early differentiation of the ovarian tumors malignancy].
Szpurek D; Moszyński R; Englert-Golon M; Pawlak M; Sajdak S
Ginekol Pol; 2006 Aug; 77(8):597-602. PubMed ID: 17076190
[TBL] [Abstract][Full Text] [Related]
12. [Color Doppler blood flow measurements and microvessel density assessment in ovarian tumors].
Czekierdowski A; Szymański M; Szumiło J; Kotarski J
Ginekol Pol; 2003 Sep; 74(9):695-700. PubMed ID: 14674110
[TBL] [Abstract][Full Text] [Related]
13. Color Doppler ultrasonography for prediction of malignant ovarian tumors.
Benjapibal M; Sunsaneevitayakul P; Boriboonhirunsarn D; Sutanthavibul A; Chakorngowit M
J Med Assoc Thai; 2002 Jun; 85(6):709-15. PubMed ID: 12322845
[TBL] [Abstract][Full Text] [Related]
14. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125.
Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R
Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205
[TBL] [Abstract][Full Text] [Related]
15. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US?
Brown DL; Frates MC; Laing FC; DiSalvo DN; Doubilet PM; Benson CB; Waitzkin ED; Muto MG
Radiology; 1994 Feb; 190(2):333-6. PubMed ID: 8284377
[TBL] [Abstract][Full Text] [Related]
16. Ascites as a predictor of ovarian malignancy.
Shen-Gunther J; Mannel RS
Gynecol Oncol; 2002 Oct; 87(1):77-83. PubMed ID: 12468346
[TBL] [Abstract][Full Text] [Related]
17. Transvaginal Doppler ultrasound with colour flow imaging in benign and malignant ovarian lesions.
Sawicki W; Spiewankiewicz B; Cendrowski K; Stelmachów J
Clin Exp Obstet Gynecol; 1995; 22(2):137-42. PubMed ID: 7781180
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors.
Jeoung HY; Choi HS; Lim YS; Lee MY; Kim SA; Han SJ; Ahn TG; Choi SJ
J Gynecol Oncol; 2008 Dec; 19(4):229-35. PubMed ID: 19471578
[TBL] [Abstract][Full Text] [Related]
19. A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer.
Tailor A; Jurkovic D; Bourne TH; Natucci M; Collins WP; Campbell S
Ultrasound Med Biol; 1996; 22(7):837-43. PubMed ID: 8923703
[TBL] [Abstract][Full Text] [Related]
20. Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer.
Buckshee K; Temsu I; Bhatla N; Deka D
Int J Gynaecol Obstet; 1998 Apr; 61(1):51-7. PubMed ID: 9622173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
